No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial
Publication
, Conference
Wagner, JE; Eapen, M; Carter, SL; Haut, PR; Peres, E; Schultz, KR; Thompson, J; Wall, DA; Kurtzberg, J
Published in: Blood
November 16, 2012
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 16, 2012
Volume
120
Issue
21
Start / End Page
359 / 359
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wagner, J. E., Eapen, M., Carter, S. L., Haut, P. R., Peres, E., Schultz, K. R., … Kurtzberg, J. (2012). No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial. In Blood (Vol. 120, pp. 359–359). American Society of Hematology. https://doi.org/10.1182/blood.v120.21.359.359
Wagner, John E., Mary Eapen, Shelly L. Carter, Paul R. Haut, Edward Peres, Kirk R. Schultz, Jason Thompson, Donna A. Wall, and Joanne Kurtzberg. “No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial.” In Blood, 120:359–359. American Society of Hematology, 2012. https://doi.org/10.1182/blood.v120.21.359.359.
Wagner JE, Eapen M, Carter SL, Haut PR, Peres E, Schultz KR, et al. No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial. In: Blood. American Society of Hematology; 2012. p. 359–359.
Wagner, John E., et al. “No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial.” Blood, vol. 120, no. 21, American Society of Hematology, 2012, pp. 359–359. Crossref, doi:10.1182/blood.v120.21.359.359.
Wagner JE, Eapen M, Carter SL, Haut PR, Peres E, Schultz KR, Thompson J, Wall DA, Kurtzberg J. No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial. Blood. American Society of Hematology; 2012. p. 359–359.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 16, 2012
Volume
120
Issue
21
Start / End Page
359 / 359
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology